53 %Among the 1447 participants, 53% (n = 766) were living with HIV.
NigeriaVIH/sidapublié 2020Journal of the International AIDS SocietyPubMeddocument de 5 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 30 / 70
53 %Among the 1447 participants, 53% (n = 766) were living with HIV.
NigeriaVIH/sidapublié 2020Journal of the International AIDS SocietyPubMeddocument de 5 observations
33,8 %Seventy (33.8%) participants were positive for HIV infection among attendees of chest clinics in Osun-State, Nigeria between June 2015 and October 15, 2016.
NigeriaVIH/sidaobservé June 2015 to October 15, 2016publié 2020Current pharmaceutical biotechnologyPubMeddocument de 10 observations
1,7 %Moderately severe depression was identified in 1.7% of the participants among people living with HIV in two rural secondary health facilities in Southwestern Nigeria between September and December 2020.
Nigeriadépression · VIH/sidaobservé September and December 2020publié 2023AIDS research and therapyPubMeddocument de 8 observations
9,1 %Of the 99 HIV-exposed infants (HEIs), 9 (9.1%) were HIV positive by the first HIV DNA PCR test.
NigeriaVIH/sidaobservé January 2018 to January 2019publié 2021Journal of tropical pediatricsPubMeddocument de 4 observations
34 %By 12 months post-ART initiation, 34% of the patients who initiated ART under the Test and Treat strategy were lost to follow-up.
NigeriaVIH/sidaobservé 12 months post-ART initiationpublié 2019PloS onePubMeddocument de 7 observations
9,3 %Dosage variation accounted for 9.3% (n=20) of the 215 drug therapy problems identified among PLWH in the study.
NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 11 observations
Transgender participants were more likely to have performed a recent HIV test compared to vulnerable cisgender women.
NigeriaVIH/sidaobservé 2021publié 2023BMC public healthPubMeddocument de 13 observations
26 687 individuals26,687 (82%) of the elderly people living with HIV had a viral load result showing less than 1000 copies/mL within one year of their last visit.
NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 15 observations
32,6 %Among 86 pregnant women in Port Harcourt, Nigeria, 14 were found to be HIV-positive, yielding a seropositivity rate of 32.6%.
NigeriaVIH/sidapublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 6 observations
42 %One hundred and seventeen (42%) of the alleged rape patients did not receive post-exposure prophylaxis for HIV/AIDS.
Nigeriarape · VIH/sidaobservé August 1 2016 to July 30 2018publié 2021Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and GynPubMeddocument de 7 observations
84 %Viral load testing coverage was 84% during the COVID-19 pandemic (55,271/69,630) compared to 73% in the pre-COVID-19 period (47,747/68,934).
NigeriaVIH/sidaobservé during COVID-19publié 2024PloS onePubMeddocument de 7 observations
23,8 per_100_person_yearsHIV incidence was 23.8 per 100 person-years among transgender women in the TRUST/RV368 cohort in Nigeria between March 2013 and February 2019.
NigeriaVIH/sidaobservé March 2013 to February 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 8 observations
27,4 %Of the 350 respondents willing to retest after delivery, 27.4% were willing to self-test.
NigeriaVIH/sidaobservé March 2021publié 2022Tropical medicine & international health : TM & IHPubMeddocument de 2 observations
95,4 %Among PLHIV at FMC Katsina, 793 (95.4%) were on first-line HAART regimen (Tenofovir-Lamivudine-Dolutegravir or Abacavir-Lamivudine-Dolutegravir).
NigeriaVIH/sidaobservé 2009–2019publié 2021BMC infectious diseasesPubMeddocument de 5 observations
42,5 %La fréquence de la neuropathie polyneuropathique chez les personnes vivant avec le VIH au Nigeria était de 42,5 % en 2013.
Nigerianeuropathie périphérique · VIH/sidaobservé 2013HAL · Unilimdocument de 747 observations
370 000 casesMother-to-child transmission of HIV has been responsible for approximately 370,000 infant HIV infections worldwide.
NigeriaVIH/sidapublié 2023Japanese journal of infectious diseasesPubMeddocument de 5 observations
26,9 %Among 412 participants with viral load data, 111 (26.9%) achieved viral suppression (<1,000 copies/mL).
NigeriaVIH/sidaobservé 2019–2021publié 2026Frontiers in public healthPubMeddocument de 7 observations
0,14 %Among 2775 pregnant women in Nigeria, the seroprevalence of triplex infection with HIV, HBV, and HCV was 0.14%.
Nigeriahépatite B · hépatite C · VIH/sidapublié 2025Antiviral therapyPubMeddocument de 7 observations
33,3 %Contacts with potentially infectious body fluid accounted for 33.3% of occupational exposures to HIV among healthcare workers.
NigeriaVIH/sidapublié 2020BMC public healthPubMeddocument de 7 observations
The missed opportunity for antiretroviral therapy initiation among antenatal care attendees ranged from 7.4% in the South West to 11.1% in the North Central in Nigeria in 2019.
NigeriaVIH/sidaobservé 2019publié 2023AIDS carePubMeddocument de 7 observations
0,8 %The prevalence of neuro-ophthalmic disorders among persons living with HIV/AIDS in Osun State, Nigeria was 0.8%.
Nigerianeuro-ophthalmic disorders · VIH/sidapublié 2026BMC ophthalmologyPubMeddocument de 9 observations
3,5 %HIV positivity rate at family index testing was 3.5% (95% CI: 2.3–5.1%).
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 16 observations
64,3 %Stigma had a major impact on mental health for 64.3% of respondents.
NigeriaVIH/sidapublié 2026Scientific reportsPubMeddocument de 6 observations
19,5 %Among 5928 persons living with HIV who initiated antiretroviral therapy with at least 6-month follow-up and one CD4 measurement, 2260 (19.5%) received efavirenz-based regimens.
NigeriaVIH/sidapublié 2020AIDS research and therapyPubMeddocument de 12 observations
10,1 %Glutathione deficiency was present in 10.10% of HIV infected children.
NigeriaVIH/sidapublié 2021West African journal of medicinePubMeddocument de 4 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.